ASCENDIS PHARMA A/S

ASNDNASDAQ

🏆 #706 by market capEarnings Nov 11US Equity

$228.07▼ $1.96 (−0.86%)

🌙 After hours$228.07▲ 0.00%Regular close · extended-hours price shown

Get earnings, price moves & breaking news on Telegram

24h▼ 0.9%

7d—

14d—

30d—

ytd—

1y—

🏦Market Cap

$14.17B

Mid Cap

📈Revenue Growth (YoY)

+90.2%

High Growth

📊Gross Margin

90.2%

High

💵FCF Margin

31.9%

Strong

⚖️P/S Ratio

11.7x

Elevated

Otter Score

84

Good

Earnings

Q3 · 2026Reported 2026-08-13

Earnings Per Share

Actual

3.29

Expected

1.71

beat

+92.40%

YoY +453.80%

Revenue

Actual

$387.48M

Expected

$376.75M

beat

+2.80%

YoY +108.20%

Consensus estimates

Recent quarters

Q3 2026

3.29

beat

Q2 2026

0.32

beat

Q1 2026

-0.64

miss

Q4 2025

-1.17

miss